Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Nu Skin Enterprises, Inc.    NUS   US67018T1051

News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

NU SKIN ENTERPRISES : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)

04/20/2015 | 06:05am US/Eastern

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;

          Appointment of Certain Officers; Compensatory Arrangements of Certain


At the direction of the Executive Compensation Committee of the Board of Directors of Nu Skin Enterprises, Inc. (the "Company"), the Company entered into an employment agreement, effective as of April 16, 2015, with Joseph Y. Chang, Chief Scientific Officer and Executive Vice President of Product Development. Dr. Chang's employment period under the employment agreement will be April 16, 2015 to December 31, 2020 unless terminated earlier. The employment agreement includes many of the same terms as Dr. Chang's previous employment agreement, which was entered into on November 9, 2009, including the following, among others:

• Compensation: Dr. Chang will receive a base salary, cash incentives, equity

   awards and other compensation, as determined by the Executive Compensation
   Committee of the Company's Board of Directors;

• Vesting upon a change in control: Time-based equity awards granted to Dr. Chang

   will fully vest upon certain terminations of employment within six months prior
   to and in connection with, or within two years following, a change in control;

• Termination payments: Dr. Chang will receive various termination payments in

specified circumstances without excise tax reimbursements;

• Consulting agreement: Upon the occurrence of certain terminations of

   employment, Dr. Chang and the Company will enter into a consulting agreement
   with a four-year term, the fees for which will be $250,000 per year less the
   amount of certain termination payments; and

• Covenants: Dr. Chang will be bound by certain covenants, including

   non-solicitation, non-competition and non-endorsement, that are in addition to,
   or supersede, previous key employee covenants.

Unlike the November 9, 2009 employment agreement, this employment agreement does not entitle Dr. Chang to an annual retention bonus. This employment agreement supersedes all previous employment letters, agreements and arrangements for Dr. Chang, including his November 9, 2009 employment agreement.

The foregoing description of the employment agreement is not intended to be complete and is qualified in its entirety by reference to the full text of the agreement, which is filed as Exhibit 10.1 hereto.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibit.

10.1 Employment Agreement, effective as of April 16, 2015 between the Company and

     Joseph Y. Chang.


© Edgar Online, source Glimpses

React to this article
04/20 NU SKIN ENTERPRISES : Change in Directors or Principal Officers, Financial State..
03/27 NU SKIN ENTERPRISES : Stocks Coverage on the Consumer Staples Sector -- Avon Pro..
03/26 NU SKIN ENTERPRISES : Gets Direct Selling Authorization for Additional City in M..
03/25 NU SKIN ENTERPRISES : Receives Direct Selling Authorization For Additional City ..
03/19 NU SKIN ENTERPRISES : Receives Direct Selling Authorization for Additional City ..
03/17 NU SKIN ENTERPRISES : CRN-I announces new membership dues structure
03/16 NU SKIN ENTERPRISES : Receives Direct Selling Authorization For Additional City ..
03/03 NU SKIN ENTERPRISES : Announces Launch Of Epoch Essential Oils
02/28 NU SKIN ENTERPRISES : Andrews & Springer LLC is Investigating Nu Skin Enterprise..
02/25 NU SKIN ENTERPRISES : Attention Investors Who Currently Hold NYSE:NUS Shares: In..
Duration : Period :
Nu Skin Enterprises, Inc. Technical Analysis Chart | NUS | US67018T1051 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes